Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer

• Waleed Kian, MD,
• Dina Levitas, MD,
• Wafeek Alguayn, MD,
• Walid Shalata, MD,
• Adam A. Sharb, MD,
• Daniel Levin, MD,
• Laila C. Roisman, PhD,
• Margarita Tokar, MD,
• Nir Peled, MD, PhD, FCCP,
• Alexander Yakobson, MD

Affiliations

Waleed Kian, MD

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

Dina Levitas, MD

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

Wafeek Alguayn, MD

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

Walid Shalata, MD

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

Adam A. Sharb, MD

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Daniel Levin, MD

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

Laila C. Roisman, PhD

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

Margarita Tokar, MD

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

Nir Peled, MD, PhD, FCCP

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel; Corresponding author. Address for correspondence: Nir Peled, MD, PhD, FCCP, The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel.

Alexander Yakobson, MD

The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel